EcoDrugPlus

Ensembl ID : ENSDLAG00005002433
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSDLAG00005003085
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSDLAG00005003397
Gene Symbol: -
Cross references: -
400 Possible Orthologues:

Ensembl ID : ENSDLAG00005003410
Gene Symbol: -
Cross references: -
351 Possible Orthologues:

Ensembl ID : ENSDLAG00005003535
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSDLAG00005004023
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSDLAG00005003234
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSDLAG00005004082
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSDLAG00005004262
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Ensembl ID : ENSDLAG00005006351
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSDLAG00005006484
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSDLAG00005006547
Gene Symbol: -
Cross references: -
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).